HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Report Contests “Unsubstantiated” Nanotech Concerns, Touts Nano-Sunscreen

This article was originally published in The Rose Sheet

Executive Summary

Current evidence suggests that nano-sized cosmetic ingredients pose no more risk to human health than their macro-sized counterparts, L'Oréal researchers maintain in a review published this month in Skin Pharmacology and Physiology

You may also be interested in...

REACH Data Requirements For Nanoform Substances Just Got Stiffer

Manufacturers and importers of nanoform substances must meet new REACH information requirements by Jan. 1, 2020, under a regulation adopted by the European Commission Dec. 3. The European Chemicals Agency is considering issuing guidance to support industry’s compliance efforts.

U.S., EU Nanotech Guidances Demonstrate “Growing Consensus” – PCPC

The Personal Care Products Council’s Jay Ansell, VP of cosmetic programs, is optimistic about the direction regulators are taking and the consensus developing among scientific experts regarding the use of nanomaterials in cosmetics. However, challenges remain for firms faced with requirements under European law, and further harmonization is needed between international regulatory regimes, he suggests.

“Physician-Led” Nanodermatology Society Endorses Nano-Sunscreens

With the summer months looming, the Nanodermatology Society announces findings from its scientific literature review, maintaining that nanotechnology in sunscreen products poses no serious health risks to consumers – certainly not in proportion to the dangers of unprotected sun exposure.

Related Content

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts